191 related articles for article (PubMed ID: 6302586)
1. [3H] Quinuclidinyl benzylate and [3H] GABA receptor binding in rat substantia nigra after 6-hydroxy-dopamine lesions.
Cross AJ; Waddington JL
Neurosci Lett; 1980 May; 17(3):271-5. PubMed ID: 6302586
[TBL] [Abstract][Full Text] [Related]
2. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
[TBL] [Abstract][Full Text] [Related]
4. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
[TBL] [Abstract][Full Text] [Related]
5. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
Das S; Matwyshyn GA; Bhargava HN
Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
[TBL] [Abstract][Full Text] [Related]
6. Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]quinuclidinyl benzilate binding in rats.
Pelham RW; Munsat TL
Brain Res; 1979 Aug; 171(3):473-80. PubMed ID: 476482
[TBL] [Abstract][Full Text] [Related]
7. Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats.
Suga M
Life Sci; 1980 Sep; 27(10):877-82. PubMed ID: 7412476
[No Abstract] [Full Text] [Related]
8. Binding experiments of muscarinic acetylcholine and dopamine receptors in human brains with emphasis on a case of striatonigral degeneration.
Shimoyama M; Kito S; Itoga E; Kishida T; Nanba K
Jpn J Pharmacol; 1982 Dec; 32(6):1157-66. PubMed ID: 6819376
[TBL] [Abstract][Full Text] [Related]
9. 6-Hydroxydopamine lesions reduce specific [3H]sulpiride binding in the rat substantia nigra: direct evidence for the existence of nigral D-2 autoreceptors.
Morelli M; Carboni E; Devoto S; Di Chiara G
Eur J Pharmacol; 1987 Aug; 140(1):99-104. PubMed ID: 3113987
[TBL] [Abstract][Full Text] [Related]
10. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
Moret C; Pastrie I; Briley M
Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
[TBL] [Abstract][Full Text] [Related]
11. gamma-Aminobutyric acid function in the rat striatum is under the double influence of nigrostriatal dopaminergic and thalamostriatal inputs: two modes of regulation?
Samuel D; Kumar U; Nieoullon A
J Neurochem; 1988 Dec; 51(6):1704-10. PubMed ID: 3141584
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic muscarinic receptors in rat myocardium: properties of [3H]quinuclidinyl benzilate [QNB] binding sites.
Mittal CK
Indian J Exp Biol; 1985 Jun; 23(6):300-5. PubMed ID: 4077129
[No Abstract] [Full Text] [Related]
13. Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride.
Filloux FM; Wamsley JK; Dawson TM
Eur J Pharmacol; 1987 Jun; 138(1):61-8. PubMed ID: 3113982
[TBL] [Abstract][Full Text] [Related]
14. Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum.
Sivam SP; Norris JC; Lim DK; Hoskins B; Ho IK
J Neurochem; 1983 May; 40(5):1414-22. PubMed ID: 6300336
[TBL] [Abstract][Full Text] [Related]
15. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
16. The effects of dopamine and dopamine agonists on the release of 3H-GABA and 3H-5HT from rat nigral slices.
Kelly E; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2655-62. PubMed ID: 3925957
[TBL] [Abstract][Full Text] [Related]
17. [Effects of diisopropylfluorophosphate, paraoxon and dichlophos on [3H] quinuclidinyl benzylate binding to the rat striatum synaptic membranes].
Golovko AI; Sofronov GA; Nikolaeva TV; Kliuntina TV
Biull Eksp Biol Med; 1992 Sep; 114(9):290-1. PubMed ID: 1477363
[TBL] [Abstract][Full Text] [Related]
18. Alteration in dopaminergic and muscarinic cholinergic receptors after subchronic treatment with haloperidol in the developing rat brain.
Kajiyama H; Nomura Y
J Pharmacobiodyn; 1981 Feb; 4(2):85-90. PubMed ID: 7196947
[TBL] [Abstract][Full Text] [Related]
19. Alterations of striatal cholinergic receptors after lesioning of the substantia nigra.
Sanvarinda Y; Phivthongngam L; Govitrapong P
Neurochem Int; 1998 Aug; 33(2):187-93. PubMed ID: 9761463
[TBL] [Abstract][Full Text] [Related]
20. A physiological role for dopamine as modulator of GABA effects in substantia nigra: supersensitivity in 6-hydroxydopamine-lesioned rats.
Waszczak BL; Walters JR
Eur J Pharmacol; 1984 Oct; 105(3-4):369-73. PubMed ID: 6439567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
